At the last check on Thursday, Evolent Health Inc.’s (NYSE:EVH) stock was down -$0.24, moving down -0.90 percent to $26.32. The average number of shares traded per day over the past five days has been 1,031,418 shares. 4 times new highs have been achieved over the past 5 days, with a $0.31 gain in that time frame. In the last twenty days, the average volume was 922,350, while in the previous 50 days, it was 895,302.
Since last month, EVH stock rose 1.35%. Shares of the company fell to $24.68 on 08/25/23, the lowest level in the past month. A 52-week high of $38.67 was reached on 05/01/23 after having rallying from a 52-week low of $21.83. Since the beginning of this year, EVH’s stock price has dropped by -6.27% or -$1.79, and marked a new high 15 times. However, the stock has declined by -31.94% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
EVH stock investors should be aware that Evolent Health Inc. (EVH) stock had its last reported insider trading activity 37 days ago on Aug 15. Rafferty Emily Ann, the Chief Operating Officer of the company, disposed of 7,900 shares for $28.05 on Aug 15. It resulted in a $221,595 divestment by the insider. Blackley Seth sold 33,011 shares at an average price of $30.78 on Jun 28. The insider now owns 783,011 shares following the transaction. On Jun 16, Chief Executive Officer Blackley Seth sold 2,098 shares at $30.16 apiece. The transaction was valued at $63,276.
Valuation Metrics
The stock’s beta is 1.51. Besides these, the trailing price-to-sales (P/S) ratio of 1.81, the price-to-book (PB) ratio of 2.68.
Financial Health
In the three months ended June 29, Evolent Health Inc.’s quick ratio stood at 1.10, while its current ratio was 1.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.58, and the total debt-to-equity ratio was 0.58. On the profitability front, the trailing twelve-month gross margin is 24.70% percent. In the year ended June 29, EBITDA margin amounted to 7.05%, whereas operating margins totaled -1.90%. Based on annual data, EVH earned $316.58 million in gross profit and brought in $1.35 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 2.90%. Return on equity (ROE) for the past 12 months was -7.80%.
In Evolent Health Inc.’s quarter-end financial report for June 29, it reported total debt of $633.01 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. EVH’s revenue rose 31.8% to $427.69 million during the quarter, while net income inched up to $469.14 million. While analysts expected Evolent Health Inc. to report $0.11 quarterly earnings, the actual figure was $0.14 per share, beating the consensus estimate by 27.30%. During the quarter, the company generated $14.95 million in EBITDA. The liabilities of Evolent Health Inc. were 1.38 billion at the end of its most recent quarter ended June 29, and its total debt was $695.81 million. The value of shareholders’ equity is $113.25 million.
Technical Picture
This quick technical analysis looks at Evolent Health Inc.’s (EVH) price momentum. With a historical volatility rate of 14.89%, the RSI 9-day stood at 51.03% on 20 September.
With respect to its five-day moving average, the current Evolent Health Inc. price is up by +1.19% percent or $0.31. At present, EVH shares trade +2.50% above its 20-day simple moving average and -27.79% percent below its 100-day simple moving average. However, the stock is currently trading approximately -8.46% below its SMA50 and -8.01% below its SMA200.
Stochastic coefficient K was 80.04% and Stochastic coefficient D was 83.21%, while ATR was 0.66. Given the Stochastic reading of 70.59% for the 14-day period, the RSI (14) reading has been calculated as 47.46%. As of today, the MACD Oscillator reading stands at 0.26, while the 14-day reading stands at 0.40.
Analyst Ratings
Stephens launched its rating on Evolent Health Inc. (NYSE: EVH) to an Overweight in a note to investors on April 12, 2023. Evolent Health Inc. (EVH) has been rated Buy by analysts. According to 0 brokerage firms, EVH is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Evolent Health Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $46.00, the current consensus forecast for the stock is $36.00 – $63.00. Based on these forecasts, analysts predict Evolent Health Inc. (EVH) will achieve an average price target of $46.88.
